Prevalence of the human papillomavirus in an inner-city indigent population with previously normal pap tests

Journal of Lower Genital Tract Disease

Volumn 12, Issue 4, 2008, Pages 287-292

  Werden, Joelene ^a,b,c   Schnatz, Peter F ^a,b   Mandavilli, Srinivas ^a   Allen, Gretchen ^a,b   Murphy, Jessica L ^a   Greene, John F ^a,b   Egan, James F X ^b   Sorosky, Joel I ^a,b,d  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^d NEW BRITAIN GENERAL HOSPITAL   (United States)

Author keywords

Cytology and dysplasia; High And low grade squamous intraepithelial lesions; Highrisk populations; Human papilloma virus; Normal pap smears

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTRACEPTION; FEMALE; HISPANIC; HUMAN; INDIGENT; INFECTION RISK; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PARITY; PREVALENCE; PROSPECTIVE STUDY; QUESTIONNAIRE; RACE DIFFERENCE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SMOKING; SOCIAL ASPECT; UTERINE CERVIX CYTOLOGY; VIRUS CULTURE; WART VIRUS;

ADOLESCENT; ADULT; AGE FACTORS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CONNECTICUT; CROSS-SECTIONAL STUDIES; FEMALE; HISPANIC AMERICANS; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PARITY; POVERTY; PREGNANCY; PREVALENCE; URBAN POPULATION; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 55149096563     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/LGT.0b013e31817e307b     Document Type: Article

References (34)

1. Farthing A, Masterson P, Mason WP, Vousden KH. Human papilloma virus detection by hybrid capture and its possible clinical use. J Clin Pathol 1994;47:649-52.
2. Hatch KD, Schneider A, Abdel-Nour MW. An evaluation of human papillomavirus testing for intermediate- and high-risk types as a triage before colposcopy. Am J Obstet Gynecol 1995;172:1150-7.
3. ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383-92.
4. Soloman D, Schiffman M, Tarone R. ALTS Study Group Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from randomized trial. J Natl Cancer Inst 2001;93:293-9.
5. Wright TC Jr., Schiffman M, Soloman D, Cox JT, Garcia F, Goldie S, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004;103:304-9.
6. Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, Lorenzato M, et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 2001;84:1616-23.
7. Kaufman RH, Adam E, Icenogle J, Reeves WC. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost effectiveness. Am J Obstet Gynecol 1997;177:930-6.
8. Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999;341:1633-8.
9. Allen LW, Maxwell S, Greene JF. Building an award-winning women's health ambulatory service and beyond. J Ambul Care Manage 2003;26:186-98.
10. Schnatz PF. The women's life center: menopause clinics help provide quality care and education. Menopause Manag 2004;13:18-32.
11. The Community Health Services. Available at: http://www.chshartford.org. Accessed January 12, 2008.
12. Becker TM, Wheeler CM, McGough NS, Jordan SW, Dorin M, Miller J, et al. Cervical papillomavirus infection and cervical dysplasia in Hispanic, Native American, and non-Hispanic white women in New Mexico. Am J Public Health 1991;81:582-6.
13. Bauer HM, Rodriquez MA, Perez-Stable EJ. Prevalence and determinants of intimate partner abuse among public hospital primary care patients. J Gen Intern Med 2000;15:811-7.
14. del Carmen MG, Findley M, Muzikansky A, Roche M, Verril CL, Horowitz N, et al. Demographic, risk factor, and knowledge differences between Latinas and non-Latinas referred to colposcopy. Gynecol Oncol 2007;104:70-6.
15. Agorastos T, Dinas KM, Lloveras B, Bosch FX, Kornegay JR, Bontis JN, et al. Cervical human papilloma-virus infection in women attending gynaecological outpatient clinics in northern Greece. Eur J Cancer Prev 2004;13:145-7.
16. Mosicicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001;285:2995-3002.
17. Lee KR, Ashfaq R, Birdsong GG, Corkill ME, McIntosh KM, Inborn SL. Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening. Obstet Gynecol 1997;90:278-84.
18. Diaz-Rosario LA, Kabawat SE. Performance of a fluid-based, thin-layer Papanicolaou smear method in the clinical setting of an independent laboratory and an outpatient screening population in New England. Arch Pathol Lab Med 1999;123:817-21.
19. Davey DD, Neal MH, Wilbur DC, Colgan TJ, Styer PE, Mody DR. Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med 2004;128:1224-9.
20. Sharpless KE, Schnatz PF, Mandavilli S, Greene JF, Sorosky JI. Dysplasia associated with atypical glandular cells on cervical cytology. Obstet Gynecol 2005;105:494-500.
21. Sharpless KE, Schnatz PF, Mandavilli S, Greene JF, Sorosky JI. Lack of adherence to practical guidelines for women with atypical glandular cells on cervical cytology. Obstet Gynecol 2005;105:501-6.
22. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
23. Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003;362:1871-6.
24. Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 2002;288:1749-57.
25. Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 2000;283:87-93.
26. Ratnam S, Franco EL, Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev 2000;9:945-51.
27. U.S. Department of Health and Human Services. Centers for Medicare and Medicaid. Medicare reimbursement schedule-physician fee schedule. Available at: http://www.cms.hhs.gov/PFSlookup. Accessed April 19, 2008.
28. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 61, April 2005: Washington, DC: American College of Obstetricians and Gynecologists; 2008:1231-44.
29. Johnson T, Schnatz PF, Johnson AM, Sorosky JI. Update on Cervical Cancer Screening. Hosp Physician 2007; 43:15-24.
30. Wright TC Jr., Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D, et al. 2006 American Society for Colposcopy and Cervical Pathology-Sponsored Consensus Conference. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol 2007;197:340-5.
31. Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001;357:1831-6.
32. Rozendaal L, Walboomers JM, van der Linden JC, Voorhorst FJ, Kenemans P, Heimerhorst TJ, et al. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer 1996;68:766-9.
33. Guido R, Schiffman M, Soloman D, Burke L. ASCUS LSIL Triage Study (ALTS) Group. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study. Am J Obstet Gynecol 2003;188:1401-5.
34. Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998;132:277-84.